Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy

British Journal of Surgery

Volumn 96, Issue 4, 2009, Pages 437-444

  Nagai, S ^a   Fujimoto, Y ^b   Kamei, H ^a   Nakamura, T ^a   Kiuchi, T ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b MITSUBISHI KYOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEPATIC MACROVESICULAR STEATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER RESECTION; LIVING DONOR; MALE; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; AGED; LENGTH OF STAY; LIVER TRANSPLANTATION; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; FATTY LIVER; HEPATECTOMY; HUMANS; HYPERBILIRUBINEMIA; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; YOUNG ADULT;

EID: 63049103129     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6479     Document Type: Article

References (42)

1. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P et al. Living donor liver transplantation -adult donor outcomes: a systematic review. Liver Transpl 2006; 12: 24-30.
2. Florman S, Miller CM. Live donor liver transplantation. Liver Transpl 2005; 12: 499-510.
3. Trotter JF, Talamantes M, McClure M,Wachs M, Bak T, Trouillot T et al. Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl 2001; 7: 485-493.
4. Fan ST, Lo CM, Liu CL, Yong BH, Chan JKF, Ng IOL. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000; 135: 336-340.
5. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-280.
6. Yokoi H, Isaji S, Yamagiwa K, Tabata M, Sakurai H, Usui M et al. Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int 2005; 18: 915-922.
7. Shah SA, Grant DR, Greig PD, McGilvray ID, Adcock LD, Girgrah N et al. Analysis and outcomes of right lobe hepatectomy in 101 consecutive living donors. Am J Transplant 2005; 5: 2764-2769.
8. Vetelainen R, Vliet A, Gouma DJ, Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 2007; 245: 20-30.
9. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-1044.
10. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998; 4: 71-77.
11. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002; 73: 325-330.
12. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298.
13. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB et al. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation. Transplant Int 2006; 19: 807-813.
14. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999; 67: 195-200.
15. Ito T, Kiuchi T, Egawa H, Kaihara S, Oike F, Ogura Y et al. Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 2003; 76: 158-163.
16. Ghobrial RM, Saab S, Lassman C, Lu DSK, Raman S, Limanond P et al. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl 2002; 8: 901-909.
17. Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139: 508-515.
18. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004; 78: 1501-1505.
19. Nadalin S, Malago M, Valentin-Gamazo C, Testa G, Baba HA, Liu C et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl 2005; 11: 980-986.
20. Marcos A, Fisher RA, Ham JM, Shiffman M, Sayal A, Luketic V et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-1379.
21. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging -correlation with histopathologic findings. Radiology 2006; 240: 116-129.
22. Kim SJ, Kim DG, Chung ES, Lee YJ, Moon IS, Lee MD. Adult living donor liver transplantation using the right lobe. Transplant Proc 2006; 38: 2117-2120.
23. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
24. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-905.
25. Rinella ME, Alonso E, Rao Sambasiva, Whitington P, Fryer J, Abecassis M et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409-414.
26. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989; 111: 473-478.
27. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114-1122.
28. Brancatelli G. Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? Radiology 2006; 239: 1-2.
29. Nakamura M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608-612.
30. Hwang S, Lee SG, Jang SJ, Cho SH, Kim KH, Ahn CH et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl 2004; 10: 721-725.
31. Cho JY, Suh KS, Kwon CH, Yi NJ, Lee HH, Park JW et al. Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl 2006; 12: 201-206.
32. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
33. Marcos A, Fisher R, Ham J, Shiffman M, Sanyal AJ, Luketic VA et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-1379.
34. Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Price LL, LewisWD et al. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 2003; 76: 5-10.
35. Cole DJ, Ferguson CM. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg 1992; 58: 88-91.
36. Belghiti J, Hiramatsu K, Benoist S, Massault PP, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J AmColl Surg 2000; 191: 38-46.
37. Beavers KL, Sandler RS, Fair JH, Johnson MW, Shrestha R. The living donor experience: donor health assessment and outcomes after living donor liver transplantation. Liver Transpl 2001; 7: 943-947.
38. Tamura S, Sugawara Y, Kaneko J, Yamashiki N, Kishi Y, Matsui Y et al. Systematic grading of surgical complications in live liver donors according to Clavien's system. Transplantation 2006; 19: 982-987.
39. Kim-Schluger L, Florman SS, Schiano T, O'Rourke M, Gagliardi R, Drooker M et al. Quality of life after lobectomy for adult liver transplantation. Transplantation 2002; 73: 1593-1597.
40. Karliova M, Mlago M, Valentin-Gamaza C, Reimer J, Treichel U, Franke GH et al. Living-related liver transplantation from the view of the donor: a 1-year follow-up survey. Transplantation 2002; 73: 1799-1804.
41. Miyagi S, Kawagishi N, Fujimori K, Sekiguchi S, Fukumori T, Akamatsu Y et al. Risks of donation and quality of donor's life after living donor liver transplantation. Transpl Int 2005; 18: 47-51.
42. Verbesey JE, Simpson MA, Pomposelli JJ, Richman E, Bracken AM, Garrigan K et al. Living donor adult liver transplantation: a longitudinal study of the donor's quality of life. Am J Transpl 2005; 5: 2770-2777.